ID   ITIH2_HUMAN             Reviewed;         946 AA.
AC   P19823; Q14659; Q15484; Q5T986;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   18-JUN-2025, entry version 218.
DE   RecName: Full=Inter-alpha-trypsin inhibitor heavy chain H2;
DE            Short=ITI heavy chain H2;
DE            Short=ITI-HC2;
DE            Short=Inter-alpha-inhibitor heavy chain 2;
DE   AltName: Full=Inter-alpha-trypsin inhibitor complex component II;
DE   AltName: Full=Serum-derived hyaluronan-associated protein;
DE            Short=SHAP;
DE   Flags: Precursor;
GN   Name=ITIH2; Synonyms=IGHEP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE,
RP   GAMMA-CARBOXYGLUTAMATION AT GLU-282 AND GLU-283, AND VARIANT SER-263.
RX   PubMed=2450046; DOI=10.1016/0014-5793(88)80798-1;
RA   Gebhard W., Schreitmueller T., Hochstrasser K., Wachter E.;
RT   "Complementary DNA and derived amino acid sequence of the precursor of one
RT   of the three protein components of the inter-alpha-trypsin inhibitor
RT   complex.";
RL   FEBS Lett. 229:63-67(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 384-865.
RX   PubMed=2446322; DOI=10.1073/pnas.84.23.8272;
RA   Salier J.-P., Diarra-Mehrpour M., Sesboue R., Bourguignon J., Benarous R.,
RA   Ohkubo I., Kurachi S., Kurachi K., Martin J.-P.;
RT   "Isolation and characterization of cDNAs encoding the heavy chain of human
RT   inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for
RT   multipolypeptide chain structure of I alpha TI.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8272-8276(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 384-766, AND VARIANT ALA-674.
RX   PubMed=2462430;
RA   Salier J.-P., Diarra-Mehrpour M., Sesboue R., Bourguignon J., Martin J.-P.;
RT   "Human inter-alpha-trypsin inhibitor. Isolation and characterization of
RT   heavy (H) chain cDNA clones coding for a 383 amino-acid sequence of the H
RT   chain.";
RL   Biol. Chem. Hoppe-Seyler 369:15-18(1988).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3663330; DOI=10.1515/bchm3.1987.368.2.963;
RA   Schreitmueller T., Hochstrasser K., Resinger P.W.M., Wachter E.,
RA   Gebhard W.;
RT   "cDNA cloning of human inter-alpha-trypsin inhibitor discloses three
RT   different proteins.";
RL   Biol. Chem. Hoppe-Seyler 368:963-970(1987).
RN   [6]
RP   PROTEIN SEQUENCE OF 55-74; 116-127; 224-246; 295-307 AND 365-385,
RP   IDENTIFICATION IN INTER-ALPHA-INHIBITOR COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=2476436; DOI=10.1016/s0021-9258(18)71575-5;
RA   Enghild J.J., Thoegersen I.B., Pizzo S.V., Salvesen G.;
RT   "Analysis of inter-alpha-trypsin inhibitor and a novel trypsin inhibitor,
RT   pre-alpha-trypsin inhibitor, from human plasma. Polypeptide chain
RT   stoichiometry and assembly by glycan.";
RL   J. Biol. Chem. 264:15975-15981(1989).
RN   [7]
RP   PROTEIN SEQUENCE OF 55-64.
RC   TISSUE=Plasma;
RX   PubMed=1384548; DOI=10.1515/bchm3.1992.373.2.1009;
RA   Malki N., Balduyck M., Maes P., Capon C., Mizon C., Han K.K., Tartar A.,
RA   Fournet B., Mizon J.;
RT   "The heavy chains of human plasma inter-alpha-trypsin inhibitor: their
RT   isolation, their identification by electrophoresis and partial sequencing.
RT   Differential reactivity with concanavalin A.";
RL   Biol. Chem. Hoppe-Seyler 373:1009-1018(1992).
RN   [8]
RP   PROTEIN SEQUENCE OF 55-64 AND 681-702, CROSS-LINK STRUCTURE, AND
RP   GLYCOSYLATION AT THR-691.
RX   PubMed=7682553; DOI=10.1016/s0021-9258(18)52933-1;
RA   Enghild J.J., Salvesen G., Thoegersen I.B., Valnickova Z., Pizzo S.V.,
RA   Hefta S.A.;
RT   "Presence of the protein-glycosaminoglycan-protein covalent cross-link in
RT   the inter-alpha-inhibitor-related proteinase inhibitor heavy chain
RT   2/bikunin.";
RL   J. Biol. Chem. 268:8711-8716(1993).
RN   [9]
RP   PROTEIN SEQUENCE OF 55-64, AND INTERACTION WITH TNFAIP6.
RX   PubMed=7516184; DOI=10.1021/bi00189a049;
RA   Wisniewski H.-G., Burgess W.H., Oppenheim J.D., Vilcek J.;
RT   "TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable
RT   complex with the serum protein inter-alpha-inhibitor.";
RL   Biochemistry 33:7423-7429(1994).
RN   [10]
RP   PROTEIN SEQUENCE OF 67-101, AND HYALURONAN BINDING.
RC   TISSUE=Serum;
RX   PubMed=7504674; DOI=10.1016/s0021-9258(19)74373-7;
RA   Huang L., Yoneda M., Kimata K.;
RT   "A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of
RT   the inter alpha-trypsin inhibitor.";
RL   J. Biol. Chem. 268:26725-26730(1993).
RN   [11]
RP   PROTEIN SEQUENCE OF 699-702, AND COVALENT LINKAGE WITH CHONDROITIN SULFATE.
RC   TISSUE=Plasma;
RX   PubMed=7513643; DOI=10.1111/j.1432-1033.1994.tb18803.x;
RA   Morelle W., Capon C., Balduyck M., Sautiere P., Kouach M., Michalski C.,
RA   Fournet B., Mizon J.;
RT   "Chondroitin sulphate covalently cross-links the three polypeptide chains
RT   of inter-alpha-trypsin inhibitor.";
RL   Eur. J. Biochem. 221:881-888(1994).
RN   [12]
RP   GLYCOSYLATION AT ASN-118; THR-666; SER-673; THR-675 AND THR-691, AND MASS
RP   SPECTROMETRY.
RX   PubMed=9677337; DOI=10.1042/bj3330749;
RA   Flahaut C., Capon C., Balduyck M., Ricart G., Sautiere P., Mizon J.;
RT   "Glycosylation pattern of human inter-alpha-inhibitor heavy chains.";
RL   Biochem. J. 333:749-756(1998).
RN   [13]
RP   GLYCOSYLATION AT ASN-118; THR-666; SER-673; THR-675 AND THR-691, AND
RP   DISULFIDE BONDS.
RX   PubMed=9425062; DOI=10.1021/bi971137d;
RA   Olsen E.H.N., Rahbek-Nielsen H., Thoegersen I.B., Roepstorff P.,
RA   Enghild J.J.;
RT   "Posttranslational modifications of human inter-alpha-inhibitor:
RT   identification of glycans and disulfide bridges in heavy chains 1 and 2.";
RL   Biochemistry 37:408-416(1998).
RN   [14]
RP   GLYCOSYLATION AT ASN-118.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-118 AND ASN-445.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-118.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   GLYCOSYLATION, STRUCTURE OF CARBOHYDRATES, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.m111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of N- and
RT   O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 11:1-17(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   PHOSPHORYLATION AT SER-60; SER-466 AND SER-886.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted phosphoproteome.";
RL   Cell 161:1619-1632(2015).
CC   -!- FUNCTION: May act as a carrier of hyaluronan in serum or as a binding
CC       protein between hyaluronan and other matrix protein, including those on
CC       cell surfaces in tissues to regulate the localization, synthesis and
CC       degradation of hyaluronan which are essential to cells undergoing
CC       biological processes.
CC   -!- SUBUNIT: I-alpha-I plasma protease inhibitors are assembled from one or
CC       two heavy chains (HC) and one light chain, bikunin. Inter-alpha-
CC       inhibitor (I-alpha-I) is composed of ITIH1/HC1, ITIH2/HC2 and bikunin.
CC       {ECO:0000269|PubMed:2476436}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- PTM: Heavy chains are linked to bikunin via chondroitin 4-sulfate
CC       esterified to the alpha-carboxyl of the C-terminal aspartate after
CC       propeptide cleavage. {ECO:0000250}.
CC   -!- PTM: N- and O-glycosylated. O-glycosylated with core 1 or possibly core
CC       8 glycans. {ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22171320,
CC       ECO:0000269|PubMed:7682553, ECO:0000269|PubMed:9425062,
CC       ECO:0000269|PubMed:9677337}.
CC   -!- PTM: Phosphorylated by FAM20C in the extracellular medium.
CC       {ECO:0000269|PubMed:26091039}.
CC   -!- MASS SPECTROMETRY: Mass=76508; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:9677337};
CC   -!- SIMILARITY: Belongs to the ITIH family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA30160.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X07173; CAA30160.1; ALT_FRAME; mRNA.
DR   EMBL; AL158044; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M18193; AAA60558.1; -; mRNA.
DR   EMBL; M33033; AAA59195.1; -; mRNA.
DR   CCDS; CCDS31141.1; -.
DR   PIR; S00346; IYHU2.
DR   RefSeq; NP_002207.2; NM_002216.3.
DR   AlphaFoldDB; P19823; -.
DR   SMR; P19823; -.
DR   BioGRID; 109904; 98.
DR   FunCoup; P19823; 283.
DR   IntAct; P19823; 75.
DR   STRING; 9606.ENSP00000351190; -.
DR   ChEMBL; CHEMBL4295727; -.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   DrugBank; DB14548; Zinc sulfate, unspecified form.
DR   GlyConnect; 285; 16 N-Linked glycans (2 sites), 5 O-Linked glycans (4 sites).
DR   GlyCosmos; P19823; 12 sites, 32 glycans.
DR   GlyGen; P19823; 18 sites, 46 N-linked glycans (3 sites), 16 O-linked glycans (14 sites).
DR   iPTMnet; P19823; -.
DR   PhosphoSitePlus; P19823; -.
DR   BioMuta; ITIH2; -.
DR   DMDM; 229462889; -.
DR   CPTAC; CPTAC-676; -.
DR   CPTAC; non-CPTAC-1134; -.
DR   jPOST; P19823; -.
DR   MassIVE; P19823; -.
DR   PaxDb; 9606-ENSP00000351190; -.
DR   PeptideAtlas; P19823; -.
DR   ProteomicsDB; 53690; -.
DR   Antibodypedia; 24443; 112 antibodies from 24 providers.
DR   DNASU; 3698; -.
DR   Ensembl; ENST00000358415.9; ENSP00000351190.4; ENSG00000151655.19.
DR   GeneID; 3698; -.
DR   KEGG; hsa:3698; -.
DR   MANE-Select; ENST00000358415.9; ENSP00000351190.4; NM_002216.3; NP_002207.2.
DR   UCSC; uc001ijs.4; human.
DR   AGR; HGNC:6167; -.
DR   CTD; 3698; -.
DR   DisGeNET; 3698; -.
DR   GeneCards; ITIH2; -.
DR   HGNC; HGNC:6167; ITIH2.
DR   HPA; ENSG00000151655; Tissue enriched (liver).
DR   MIM; 146640; gene.
DR   OpenTargets; ENSG00000151655; -.
DR   VEuPathDB; HostDB:ENSG00000151655; -.
DR   eggNOG; ENOG502QPS2; Eukaryota.
DR   GeneTree; ENSGT00940000157945; -.
DR   InParanoid; P19823; -.
DR   OMA; AKQMWAY; -.
DR   OrthoDB; 299997at2759; -.
DR   PAN-GO; P19823; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; P19823; -.
DR   PathwayCommons; P19823; -.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SignaLink; P19823; -.
DR   BioGRID-ORCS; 3698; 12 hits in 1143 CRISPR screens.
DR   ChiTaRS; ITIH2; human.
DR   GeneWiki; ITIH2; -.
DR   GenomeRNAi; 3698; -.
DR   Pharos; P19823; Tbio.
DR   PRO; PR:P19823; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P19823; protein.
DR   Bgee; ENSG00000151655; Expressed in liver and 116 other cell types or tissues.
DR   ExpressionAtlas; P19823; baseline and differential.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0030212; P:hyaluronan metabolic process; IEA:InterPro.
DR   CDD; cd01461; vWA_interalpha_trypsin_inhibitor; 1.
DR   FunFam; 3.40.50.410:FF:000013; inter-alpha-trypsin inhibitor heavy chain H2; 1.
DR   Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 1.
DR   InterPro; IPR010600; ITI_HC_C.
DR   InterPro; IPR050934; ITIH.
DR   InterPro; IPR013694; VIT.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10338; INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN FAMILY MEMBER; 1.
DR   PANTHER; PTHR10338:SF14; INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN H2; 1.
DR   Pfam; PF06668; ITI_HC_C; 1.
DR   Pfam; PF08487; VIT; 1.
DR   Pfam; PF00092; VWA; 1.
DR   SMART; SM00609; VIT; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; vWA-like; 1.
DR   PROSITE; PS51468; VIT; 1.
DR   PROSITE; PS50234; VWFA; 1.
DR   neXtProt; NX_P19823; -.
DR   PharmGKB; PA29965; -.
DR   TreeFam; TF328982; -.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Gamma-carboxyglutamic acid;
KW   Glycoprotein; Phosphoprotein; Protease inhibitor; Proteoglycan;
KW   Proteomics identification; Reference proteome; Secreted;
KW   Serine protease inhibitor; Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   PROPEP          19..54
FT                   /id="PRO_0000016517"
FT   CHAIN           55..702
FT                   /note="Inter-alpha-trypsin inhibitor heavy chain H2"
FT                   /id="PRO_0000016518"
FT   PROPEP          703..946
FT                   /id="PRO_0000016519"
FT   DOMAIN          56..185
FT                   /note="VIT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00801"
FT   DOMAIN          308..468
FT                   /note="VWFA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT   REGION          665..679
FT                   /note="O-glycosylated at three sites"
FT   MOD_RES         60
FT                   /note="Phosphoserine; by FAM20C"
FT                   /evidence="ECO:0000269|PubMed:26091039,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         282
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000269|PubMed:2450046"
FT   MOD_RES         283
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000269|PubMed:2450046"
FT   MOD_RES         466
FT                   /note="Phosphoserine; by FAM20C"
FT                   /evidence="ECO:0000269|PubMed:26091039"
FT   MOD_RES         702
FT                   /note="Aspartate 1-(chondroitin 4-sulfate)-ester"
FT   MOD_RES         886
FT                   /note="Phosphoserine; by FAM20C"
FT                   /evidence="ECO:0000269|PubMed:26091039"
FT   CARBOHYD        118
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:9425062, ECO:0000269|PubMed:9677337"
FT                   /id="CAR_000140"
FT   CARBOHYD        445
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        666
FT                   /note="O-linked (GalNAc...) threonine; partial"
FT                   /evidence="ECO:0000269|PubMed:9425062,
FT                   ECO:0000269|PubMed:9677337"
FT                   /id="CAR_000214"
FT   CARBOHYD        673
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000269|PubMed:9425062,
FT                   ECO:0000269|PubMed:9677337"
FT                   /id="CAR_000215"
FT   CARBOHYD        675
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:9425062,
FT                   ECO:0000269|PubMed:9677337"
FT                   /id="CAR_000216"
FT   CARBOHYD        691
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:7682553,
FT                   ECO:0000269|PubMed:9425062, ECO:0000269|PubMed:9677337"
FT                   /id="CAR_000217"
FT   DISULFID        261..264
FT                   /evidence="ECO:0000269|PubMed:9425062"
FT   DISULFID        650..651
FT                   /evidence="ECO:0000269|PubMed:9425062"
FT   VARIANT         263
FT                   /note="N -> S (in dbSNP:rs7075296)"
FT                   /evidence="ECO:0000269|PubMed:2450046"
FT                   /id="VAR_055248"
FT   VARIANT         569
FT                   /note="L -> V (in dbSNP:rs7084817)"
FT                   /id="VAR_055249"
FT   VARIANT         674
FT                   /note="P -> A (in dbSNP:rs3740217)"
FT                   /evidence="ECO:0000269|PubMed:2462430"
FT                   /id="VAR_055250"
FT   CONFLICT        374
FT                   /note="K -> L (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        705
FT                   /note="F -> S (in Ref. 3; AAA60558 and 4; AAA59195)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        729
FT                   /note="N -> D (in Ref. 3; AAA60558 and 4; AAA59195)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        731
FT                   /note="V -> A (in Ref. 3; AAA60558 and 4; AAA59195)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   946 AA;  106463 MW;  BA626B146DDC2A5F CRC64;
     MKRLTCFFIC FFLSEVSGFE IPINGLSEFV DYEDLVELAP GKFQLVAENR RYQRSLPGES
     EEMMEEVDQV TLYSYKVQST ITSRMATTMI QSKVVNNSPQ PQNVVFDVQI PKGAFISNFS
     MTVDGKTFRS SIKEKTVGRA LYAQARAKGK TAGLVRSSAL DMENFRTEVN VLPGAKVQFE
     LHYQEVKWRK LGSYEHRIYL QPGRLAKHLE VDVWVIEPQG LRFLHVPDTF EGHFDGVPVI
     SKGQQKAHVS FKPTVAQQRI CPNCRETAVD GELVVLYDVK REEKAGELEV FNGYFVHFFA
     PDNLDPIPKN ILFVIDVSGS MWGVKMKQTV EAMKTILDDL RAEDHFSVID FNQNIRTWRN
     DLISATKTQV ADAKRYIEKI QPSGGTNINE ALLRAIFILN EANNLGLLDP NSVSLIILVS
     DGDPTVGELK LSKIQKNVKE NIQDNISLFS LGMGFDVDYD FLKRLSNENH GIAQRIYGNQ
     DTSSQLKKFY NQVSTPLLRN VQFNYPHTSV TDVTQNNFHN YFGGSEIVVA GKFDPAKLDQ
     IESVITATSA NTQLVLETLA QMDDLQDFLS KDKHADPDFT RKLWAYLTIN QLLAERSLAP
     TAAAKRRITR SILQMSLDHH IVTPLTSLVI ENEAGDERML ADAPPQDPSC CSGALYYGSK
     VVPDSTPSWA NPSPTPVISM LAQGSQVLES TPPPHVMRVE NDPHFIIYLP KSQKNICFNI
     DSEPGKILNL VSDPESGIVV NGQLVGAKKP NNGKLSTYFG KLGFYFQSED IKIEISTETI
     TLSHGSSTFS LSWSDTAQVT NQRVQISVKK EKVVTITLDK EMSFSVLLHR VWKKHPVNVD
     FLGIYIPPTN KFSPKAHGLI GQFMQEPKIH IFNERPGKDP EKPEASMEVK GQKLIITRGL
     QKDYRTDLVF GTDVTCWFVH NSGKGFIDGH YKDYFVPQLY SFLKRP
//
